Compare RES & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RES | NEO |
|---|---|---|
| Founded | 1984 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Precision Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | N/A | 1999 |
| Metric | RES | NEO |
|---|---|---|
| Price | $5.44 | $11.79 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $5.24 | ★ $11.38 |
| AVG Volume (30 Days) | ★ 1.7M | 1.6M |
| Earning Date | 01-29-2026 | 02-17-2026 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $1,536,150,000.00 | $709,162,000.00 |
| Revenue This Year | $16.18 | $10.87 |
| Revenue Next Year | $3.71 | $9.84 |
| P/E Ratio | $24.97 | ★ N/A |
| Revenue Growth | 4.20 | ★ 10.10 |
| 52 Week Low | $4.10 | $4.72 |
| 52 Week High | $7.17 | $19.12 |
| Indicator | RES | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 47.44 | 50.65 |
| Support Level | $5.36 | $12.18 |
| Resistance Level | $5.54 | $12.42 |
| Average True Range (ATR) | 0.16 | 0.37 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 13.45 | 27.78 |
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.